Health Care: Drugs

Allergan Inc (AGN: NYSE)

$232.4 -0.08 | -0.03%
02/26/15 - 04:00 PM ET
Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 1.53B 988.70M 1.10B 938.10M
Operating Gains/Losses 15.20M 417.40M 5.70M 5.90M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -115.70M -139.60M -34.30M -105.60M
(Increase) Decrease in Inventories -43.80M -26.90M -7.30M -24.00M
(Increase) Decrease In Other Current Assets -23.30M -800.00K -16.00M -33.10M
(Decrease) Increase In Payables 1.90M 37.40M 32.70M -19.30M
(Decrease) Increase In Other Current Liabilities 115.90M 175.10M 125.50M 19.30M
(Increase) Decrease In Other Working Capital -128.20M 1.60M 70.80M 200.00K
Other Non-Cash Items 420.90M 191.90M 157.80M 107.50M
Net Cash From Continuing Operations 1.93B 1.70B 1.60B 1.08B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 1.93B 1.70B 1.60B 1.08B
Sale of Property, Plant & Equipment 500.00K 500.00K 1.80M 1.20M
Cash Used for Investing Activities
Sale of Short-Term Investments 1.82B 683.20M 784.60M 1.14B
Purchases of Property, Plant & Equipment -277.90M -184.00M -161.30M -130.10M
Acquisitions -65.70M -849.40M -349.20M -101.40M
Purchases of Short-Term Investments -1.27B -1.03B -865.20M -571.10M
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 182.70M -1.38B -589.30M 340.80M
Issuance of Debt 0.00 598.50M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 521.00M 179.30M 246.40M 264.00M
Repayment of Long-Term Debt 0.00 0.00 0.00 -808.90M
Repurchase of Capital Stock -839.20M -650.70M -909.00M -461.70M
Payment of Cash Dividends -59.60M -77.40M -60.40M -61.10M
Other Financing Charges, Net 173.80M -21.50M 5.50M 65.40M
Net Cash From Financing Activities -204.00M 28.20M -717.50M -1.00B
Effect of Exchange Rate Changes -41.20M -4.00M 2.60M -5.50M
Net Change in Cash & Cash Equivalents 1.87B 344.30M 295.70M 414.90M

Portfolios with AGN

Latest AGN Headlines from TheStreet

More Financial News for AGN

Press Releases for AGN

See All Press Releases

Partner Headlines for AGN

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter